Choice of Methodology Impacts Outcome in Indirect Comparisons of Drugs for Idiopathic Pulmonary Fibrosis

Background and Objectives: Idiopathic pulmonary fibrosis (IPF) is a chronic condition leading to lung damage and deterioration in lung function. Following the availability of two new drugs, nintedanib and pirfenidone, a number of network meta-analyses (NMAs) of randomised controlled trials have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Scott, David A., Loveman, Emma, Colquitt, Jill L., O’Reilly, Katherine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723644/
https://www.ncbi.nlm.nih.gov/pubmed/31390809
http://dx.doi.org/10.3390/medicina55080443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6723644/
https://www.ncbi.nlm.nih.gov/pubmed/31390809
http://dx.doi.org/10.3390/medicina55080443

Ejemplares similares